12:00 AM
Jun 19, 2000
 |  BC Week In Review  |  Company News  |  Deals

Medarex, MedImmune Inc. deal

MEDI received an exclusive worldwide license to use MEDX's HuMAb-mouse technology to develop antibodies against respiratory...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >